Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro

Cell Biology and Toxicology

Volumn 13, Issue 3, 1997, Pages 141-153

  Gonindard, C ^a   Bergonzi, C ^b   Denier, C ^b   Sergheraert, C ^c   Klaebe, A ^b   Chavant, L ^a   Hollande, E ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Université Paul Sabatier   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

anti neoplastic drug; cancer; hispidin; keratinocyte; protein kinase C

Indexed keywords

HISPIDIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PANCREAS CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS; BASIDIOMYCOTA; CARCINOMA, SQUAMOUS CELL; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; FACIAL NEOPLASMS; FIBROBLASTS; GROWTH INHIBITORS; HUMANS; KERATINOCYTES; LUNG; MALE; PANCREATIC NEOPLASMS; PROTEIN KINASE C; PYRONES; TUMOR CELLS, CULTURED;

EID: 0030959893     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007321227010     Document Type: Article

References (43)

1. Andreu JM, Gorbunoff MJ, Medrano FJ, Rossi M, Timasheff SN. Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring-C′ of biphenyl analogs. Biochemistry. 1991;30:3777-86.
2. Ardalan B, Glazer R. An update on the biochemistry of 5-fluorouracil. Cancer Treat Rev. 1981;8:157-67.
3. Bishop WR, Pachter JA, Pai JK. Regulation of phospholipid hydrolysis and 2nd messenger formation by protein kinase C. Adv Enzyme Regul. 1992;32:177-92.
4. Blum RH, Carter SK. Adriamycin: a new anti-cancer drug with significant clinical activity. Ann Int Med. 1974;80:249-59.
5. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA. 1986;83:5822-4.
6. Boukamp P, Tilgen W, Dzarlieva RT et al. Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst. 1982;68:415-22.
7. Boukamp P, Rupniak TR, Fusenig NE. Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines. Cancer Res. 1985;45:5582-92.
8. Brautigan DL. Protein phosphatases. Recent Prog Hormone Res. 1994;49:197-214.
9. Chadwich M, Rogers WI. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. Cancer Res. 1972;32:1045-56.
10. Chang BK. Differential sensitivity of pancreatic adenocarcinoma cell lines to chemotherapeutic agents in culture. Cancer Treat Rev. 1983;67:355-61.
11. Cohen GL, Bauer WR, Barton JK, Lippard SJ. Binding of cis-and trans-dichlorodiammineplatinum (II) to DNA: evidence for unwinding and shortening of the double helix. Science. 1979;203:1014-6.
12. Cohen P. The discovery of protein phosphatases: from chaos and confusion to an understanding of their role in cell regulation and human disease. Bioassays. 1994; 16:583-8.
13. Dechecchi MC, Tamanini A, Berton G, Cabrini G. Protein kinase C activates chloride conductance in C127 cells stably expressing the cystic fibrosis gene. J Biol Chem. 1993;268: 11321-5.
14. Edwards RL, Wilson DV. Constituents of the higher fungi. Part II. The synthesis of hispidin. J Chem Soc. 1961;4:5003-4.
15. Edwards RL, Lewis DG, Wilson DV. Constituents of the higher fungi. Part I. Hispidin, a new 4-hydroxy-6-styryl-2-pyrone from Polyporus hispidus. J Chem Soc. 1961;4:4995-5002.
16. Fögh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977;59:221-6.
17. Gali RR, Pugazhenthi S, Chandelier RL. Reciprocal effects on the protein kinase C inhibitors staurosporine and H-7 on the regulation of glycol synthetase and phosphorases in the primary culture of hepatocytes. Metab Clin Exp. 1993;42: 1475-80.
18. Gonda Y, Nishizawa K, Ando S et al. Involvement of protein kinase-C in the regulation of assembly-disassembly of neurofilaments in vitro. Biochem Biophys Res Commun. 1990;167:1316-25.
19. Hagiwara M, Inoue S, Tanaka T, Nunoki K, Ito M, Hikada H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol. 1988;37:2987-92.
20. Hartmann KU, Heidelberger C. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase. J Biol Chem. 1961;236:3006-13.
21. Hollande E, Levrat Di Donato JH et al. Calcium phosphate deposits in domes of human pancreatic adenocarcinoma (Capan-1) cell cultures. Bio Cell. 1990;69:191-203.
22. Ingebritsen TS, Cohen P. The protein phosphatases involved in cellular regulation. I. Classification and substrate specificities. Eur J Biochem. 1983;132:255-61.
23. Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature. 1970;227:168-70.
24. Jiang JB, Hesson DP, Dusak BA, Dexter DL, Kang GH, Hamel E. Synthesis and biological evaluation of 2-styrylquinazolin-4 (3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J Med Chem. 1990;33:1721-8.
25. Kyriazis AP, Kyriazis AA, Scarpelli DG, Fögh J, Rao MS, Lepera R. Human pancreatic adenocarcinoma cell line Capan-1 in tissue culture and the nude mouse. Morphologic, biologic and biochemical characteristics. Am J Pathol. 1982;106:250-60.
26. Levitzki A. Signal-transduction therapy. A novel approach to disease management. Eur J Biochem. 1994;226:1-13.
27. - antiport. J Membrane Biol. 1991;119: 179-86.
28. Mahieu I, Becq F, Wolfensberger T, Gola M, Carter N, Hollande E. The expression of carbonic anhydrases II and IV in the human pancreatic cancer cell line (Capan-1) is associated with bicarbonate ion channels. Biol Cell. 1994; 81:131-41.
29. Malet-Martino M-C, Faure F, Vialaneix J-P, Palévody C, Hollande E, Martino R. Non-invasive fluorine 19-NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma. Cancer Chemother Pharmacol. 1986;18:5-10.
30. Mullivor RA, Plutkin LI, Harris H. Differential inhibition of the products of the human alkaline phosphatase loci. Ann Hum Genet. 1978;42:1-13.
31. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988; 334:661-5.
32. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9:484-96.
33. Pawson T. Introduction: protein kinases. FASEB J. 1994;8: 1112-3.
34. Ricouart A, Gesquiere JC, Tartar A, Sergheraert C. Design of potent protein kinase inhibitors using the bisubstrate approach. J Med Chem. 1991;34:73-8.
35. Roberts JJ, Pascoe JM. Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds. Nature. 1972;235:282-4.
36. Rosenberg B, Van Camp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumor agents. Nature. 1969;222:385-6.
37. 2 synthesis in human amnion by protein kinase-C. Prostaglandins. 1990; 39:355-63.
38. Skoufias DA, Wilson L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry. 1992;31:738-46.
39. 2+ dependent protein kinase. Biochem Biophys Res Commun. 1986;135:397-403.
40. Tarasiuk J, Kolodziejczyk P, Borowski E. Enzymatic studies of the effect of Cu (II) on oxygen radical production stimulated by daunorubicin and ametantrone. Biochem Pharmacol. 1990;39:1405-10.
41. Walsh DA, Van Patten SM. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J. 1994;8:1227-36.
42. Walton KM, Dixon JE. Protein tyrosine phosphatase. Annu Rev Biochem. 1993;62:101-20.
43. Wurzer JC, Tallarida RJ, Sirover MA. New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells. J Pharmacol Exp Ther. 1994;269:39-43.